Here’s what you need to know.
1. The device is designed to improve adenoma detection rates during a colonoscopy over standard colonoscopy.
2. Peer-reviewed studies are still required for the Endocuff Vision, a device Olympus recently launched.
3. The material, hinge design and moment of force are similar among the two devices.
4. An FDA analysis determined that Endocuff results in a “statistically and clinically relevant improvement in adenoma detection rate, as compared to unassisted colonoscopy.” The analysis was based on several multi-center studies.
More articles on gastroenterology/endoscopy:
Olympus, Boston Scientific & more — 3 GI company key notes
GI leader to know: Dr. Eric Osgard of Gastroenterology Consultants
ACG creates new clinical guideline for abnormal liver chemistries: 5 things to know
